5hon MSN
Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs
More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results